- Disease: Post-COVID-19
- Study type: Randomised Clinical Trial, Treatment
- Study type descriptors: Interventional
- Objective: To evaluate the efficacy of allopurinol therapy for improving cardiovascular outcomes in patients at high and very high cardiovascular risk
- Number of participants enrolled: Enrollment ongoing
- Study enrolling from
- Study includes follow-up for 5 years
Study Data
- Adults (18-64 years)
- Elderly (≥65 years)
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Allopurinol
External Links
Other information
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to